Integra Lifesciences Holdings Corp (NASDAQ:IART)
| 41.27 Delayed Data As of Dec 08 |  -0.04 / -0.10%Today’s Change | 33.44 Today|||52-Week Range 60.69 | -26.40% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 52.2M | 102.1M | 174.9M | 138.8M | |
| Short Term Investment Cash | -19.8M | 53.9M | 72.9M | -36.1M | ||
| Cash & Short Term Investments | 52.2M | 102.1M | 174.9M | 138.8M | ||
| Receivables | Receivables | 132.2M | 148.2M | 251.8M | 269.9M | |
| Inventories | Inventories | 211.4M | 217.3M | 296.3M | 280.3M | |
| Current Assets | Other Current Assets | 42.6M | 27.7M | 99.1M | 86.0M | |
| Current Assets | 438.5M | 495.2M | 822.1M | 775.1M | ||
| Total Assets | Property, Plant and Equipment - Gross | 373.7M | 413.2M | 489.2M | 555.3M | |
| Depreciation | -168.5M | -190.8M | -219.9M | -255.2M | ||
| Intangible Assets | 1.1B | 1.1B | 2.1B | 2.0B | ||
| Other Assets | 1.1B | 1.1B | 2.1B | 2.0B | ||
| Total Assets | 1.8B | 1.8B | 3.2B | 3.1B | ||
| Liabilities | Accounts Payable | 34.8M | 29.1M | 94.0M | 76.1M | |
| Short Term Debt | 14.4M | 0.00 | 60.0M | 22.5M | ||
| Accrued Expenses | 39.2M | 34.8M | 87.7M | 80.7M | ||
| Other Current Liabilities | 44.8M | 41.8M | 121.6M | 88.3M | ||
| Other Liabilities | 139.1M | 123.6M | 348.9M | 262.6M | ||
| Total Liabilities | Long Term Debt | 700.6M | 665.0M | 1.8B | 1.3B | |
| Deferred Taxes | -148.0M | -142.0M | -58.9M | -51.0M | ||
| Other Liabilities | 28.6M | 8.7M | 31.7M | 49.5M | ||
| Total Liabilities | 1.0B | 968.3M | 2.2B | 1.7B | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 751.4M | 839.7M | 962.3M | 1.4B | ||
| Total Shareholder Equity | 751.4M | 839.7M | 962.3M | 1.4B | ||
| Share Information | Common Shares Outstanding | 73.9M | 74.7M | 78.4M | 85.2M | |
| Addtl. Info. | No data currently available for this section. | |||||
